The ISSF

IPOD Articles

2023
- Name
  2023-IPOD-3-Reminders-about-the-risks-associated-with-supplement-use.pdf
  2023-IPOD-2_2022-Year-End-Report.pdf
  2023-IPOD-1st-Edition-2023-ADEL-Resources.pdf

Articles 2022

Name
2022_IPOD-6_WADA-Prohibited-List-2023.pdf
2022_IPOD-5_Education-on-Privacy-and-Information-Security-Awareness.pdf
2022_IPOD-4_Reminders-about-the-risks-associated-with-supplement-use.pdf
2022_IPOD-3_Webinar-for-athletes-on-the-List-and-TUEs.pdf
2022_IPOD-2_Key-areas-of-athlete-vulnerabilities-to-doping.pdf
2022_IPOD-1_2021-Year-End-Report.pdf

Articles 2021
- Name
  2021_IPOD-3_2022-Prohibited-List.pdf
  2021_IPOD-2_Important-anti-doping-reminders-before-Tokyo-OGs.pdf
  2021_IPOD-1_2020-Year-End-Report.pdf

Articles 2020
- Name
  2020_IPOD-3_2021-Prohibited-List.pdf
  2020_IPOD-2_Notice-on-revised-ISSF-Anti-Doping-Rules-coming-into-effect-January-1-2021.pdf
  2020_IPOD-1_2019-Year-End-Report.pdf

Articles 2019

Name
2019_IPOD-6_2020-Prohibited-List.pdf
2019_IPOD-5_Reminders-to-Athletes-on-risks-of-taking-supplements.pdf
2019_IPOD-4_Reminders-to-Verify-Medication.pdf
2019_IPOD-3_Roles-Responsibilities-and-Duties-of-all-ISSF-Athletes.pdf
2019_IPOD-2_Therapeutic-Use-Exemptions.pdf
2019_IPOD-1_Risks-of-supplement-use-and-Inadvertent-doping.pdf

Articles 2018

Name
2018_IPOD-6_Youth-Olympic-Games-ISSF-Focus-Day.pdf
2018_IPOD-5_Testing-at-the-Changwon-World-Championships.pdf
2018_IPOD-4_Focus-on-the-WADA-Athletes-Committee.pdf
2018_IPOD-3_ADEL-the-new-Anti-Doping-E-Learning-Platform.pdf
2018_IPOD-2_Monitoring-Compliance-to-the-ISSF-Anti-Doping-Rules-and-the-World-Anti-Doping-Code.pdf
2018_IPOD-1_2017-Anti-Doping-Report-and-Looking-Ahead-to-2018.pdf

Articles 2017

Name
2017_IPOD-6_The-ISSF-Anti-Doping-Committee-and-Code-Compliance.pdf
2017_IPOD-5_An-Ongoing-Debate.pdf
2017_IPOD-4_Speaking-Out-on-Doping.pdf
2017_IPOD-3_ISSF-Compliance-with-the-World-Anti-Doping-Code.pdf
2017_IPOD-2_Test-Your-Anti-Doping-Knowledge.pdf
2017_IPOD-1_2016-Anti-Doping-Report-and-Looking-Ahead-to-2017.pdf

Articles 2016

Name
2016_IPOD-6_Privacy-Issues-in-Anti-Doping.pdf
2016_IPOD-4_Take-the-Anti-Doping-Quiz.pdf
2016_IPOD-3_The-IPOD-answers-questions-on-Meldonium-and-Jurisdiction-over-Athletes-at-the-OGs.pdf
2016_IPOD-2_Education-and-Awareness-Successful-Anti-Doping-Programs.pdf
2016_IPOD-1_2015-Anti-Doping-Report-and-Looking-ahead-to-2016.pdf

Articles 2015

Name
2015_IPOD-6_Prohibited-Association-Explained.pdf
2015_IPOD-5_Substantial-Assistance-Explained.pdf
2015_IPOD-4_Interview-with-ISSF-Athletes-Committee-Chairman-Abhinav-Bindra.pdf
2015_IPOD-3_The-WADA-ADO-Symposium-Intelligence-Based-Testing-The-ISSF-RTP.pdf
2015_IPOD-2_The-IPOD-answers-questions-on-Supplements-Use-and-TUEs.pdf
2015_IPOD-1_2014-Anti-Doping-Report-and-looking-ahead-to-2015.pdf

Articles 2014

Name
2014_IPOD-6_The-2015-ISSF-Anti-Doping-Rules.pdf
2014_IPOD-5_Therapeutic-Use-Exemptions-Process.pdf
2014_IPOD-4_A-New-and-Revised-World-Anti-Doping-Code.-Part-III.pdf
2014_IPOD-3_A-New-and-Revised-World-Anti-Doping-Code.-Part-II.pdf
2014_IPOD-2_A-New-and-Revised-World-Anti-Doping-Code.-Part-I.pdf
2014_IPOD-1_2013-Anti-Doping-Report.pdf

Articles 2013

Name
2013_IPOD-6_Looking-head-to-2014.pdf
2013_IPOD-5_The-IPOD-answers-3-questions-from-its-readers.pdf
2013_IPOD-4_The-IPOD-answers-6-questions-from-its-readers.pdf
2013_IPOD-3_ISSFs-Role-in-Anti-Doping-Education-and-Prevention.pdf
2013_IPOD-2_WADA-Accredited-Laboratories-for-Doping-Control-Analysis.pdf
2013_IPOD-1_2012-Anti-Doping-Report-and-looking-ahead-to-2013.pdf

Articles 2012

Name
2012_IPOD-5_2013-Prohibited-List.pdf
2012_IPOD-4_Anti-Doping-at-the-2012-Summer-Olympic-Games-in-London.pdf
2012_IPOD-3_Focus-on-Regional-Anti-Doping-Organisations-RADOs.pdf
2012_IPOD-2_World-Anti-Doping-Code-review-process-and-Risks-of-Supplements.pdf
2012_IPOD-1_2011-Anti-Doping-Report.pdf

Articles 2011

Name
2011_IPOD-6_2012-Prohibited-List.pdf
2011_IPOD-5_Supplements-Risks-vs-Rewards.pdf
2011_IPOD-4_The-IPOD-answers-3-questions-from-its-readers.pdf
2011_IPOD-3_The-IPOD-answers-2-questions-from-its-readers.pdf
2011_IPOD-2_The-IPOD-answers-3-questions-from-its-readers.pdf
2011_IPOD-1_2010-Anti-Doping-Report.pdf

Articles 2010

Name
2010_IPOD-6_Looking-ahead-to-ISSFs-Anti-Doping-Initiatives-for-2011.pdf
2010_IPOD-5_Focus-on-the-ISSF-Medical-Committee.pdf
2010_IPOD-4_The-Importance-of-Anti-Doping-Education.pdf
2010_IPOD-3_Focus-on-WADA-the-World-Anti-Doping-Agency.pdf
2010_IPOD-2_The-WADA-Prohibited-List.pdf
2010_IPOD-1_2009-Anti-Doping-Report.pdf

Articles 2009

Name
2009_IPOD-6_The-IOC-Medical-Commission-and-WADA.pdf
2009_IPOD-5_Beware-of-Beta-Blockers.pdf
2009_IPOD-4_Abbreviated-Therapeutic-Use-Exemptions.pdf
2009_IPOD-3_Q-A-on-Therapeutic-Use-Exemptions.pdf
2009_IPOD-2_Q-A-on-Prohibited-Substances-the-IPOD-quiz.pdf

Documents & Forms

Information for all - Anti-Doping and Clean Sport

Therapeutic Use Exemption

ISSF Anti-Doping Rules

ISSF Registered Testing Pool

ISSF Outreach Posters

ISSF Information Portal on Doping - IPOD

Education and Awareness

WADA Docs & Forms

2021 World-Anti-Doping Code

International Standards

2023 Prohibited List

2023 Summary of Major Modifications and Explanatory Notes

2023 Monitoring Program

News Anti-Doping

ISSF Partners